Stem Cell Clinic

Stem Cell Concentration System Market is Anticipated to Register a Value of XX Million by the end of 2018 2028 – 3rd Watch News

By Stell Cell Research

The Stem Cell Concentration System market study Added by Market Study Report provides an in-depth analysis pertaining to potential drivers fueling this industry. The study also encompasses valuable insights about profitability prospects, market size, growth dynamics, and revenue estimation of the business vertical. The study further draws attention to the competitive backdrop of renowned market contenders including their product offerings and business strategies.

The report gives a far-reaching examination of the Stem Cell Concentration System industry advertise by sorts, applications, players and locales. This report additionally shows the 2014-2024 generation, Consumption, income, Gross edge, Cost, Gross, piece of the overall industry, CAGR, and Market impacting elements of the Stem Cell Concentration System industry.

Request Sample Report @ https://www.futuremarketinsights.co/reports/sample/REP-GB-7707

A rundown of the competitive spectrum:

Key Players

Some of the global key participants operating in stem cell concentration system market are: EmCyte Corporation, Zimmer Biomet, Harvest Technologies, Argos Technologies, Inc., Perkin Elmer, Inc., Arthrex, Inc., Avita Medical, Teleflex, Inc., Terumo Corporation and others

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

Regional analysis includes:

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:

NOTE All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Future Market Insights.

In-depth information about the sales volume and the market share accumulated by each of the company, in addition to the revenue margin of every player is elucidated.

A basic outline of the company, along with its chief rivals and its manufacturing base has also been provided.

The report encompasses, in minute detail, information regarding the products manufactured by every company of Stem Cell Concentration System market, product specifications, as well as their application scope.

The report is also inclusive the price patterns and the gross margins of the industry magnates.

The revenue and market share accumulated by every region has been enumerated in the report, in addition to the sales forecast and the volume.

The present status of the regional markets in this business sphere in addition to the prospects that every region holds in Stem Cell Concentration System market in the years to come has been provided.

The projected growth rate of every region in Stem Cell Concentration System market over the forecast timeline has also been discussed about.

Request Methodology On This Report @ https://www.futuremarketinsights.co/askus/REP-GB-7707

An outline of the Stem Cell Concentration System market segmentation:

The report elucidates the Stem Cell Concentration System market in terms of the product landscape, split into Medical Service and Medicine Marketing.

Details regarding the revenue amassed by every product in tandem with the volume share have been enlisted.

The market share accumulated by every product in Stem Cell Concentration System market has been specified as well.

The report is inclusive of the application landscape of this industry, segmented into Hospitals and Clinics.

The study encompasses the revenue that every application segment accounts for, as well as the volume and market share of the application.

We offer tailor-made solutions to fit your requirements, request[emailprotected] https://www.futuremarketinsights.co/customization-available/REP-GB-7707

The Stem Cell Concentration System market report enumerates quite some details about the factors impacting the industry, influence of technological developments on the vertical, risks, as well as the threats that substitutes present to the industry players. In addition, information about the changing preferences and needs of consumers in conjunction with the impact of the shifting dynamics of the economic and political scenario on the Stem Cell Concentration System market has also been acknowledged in the study.

Highlights of the Stem Cell Concentration System market report:

See the original post here:
Stem Cell Concentration System Market is Anticipated to Register a Value of XX Million by the end of 2018 2028 - 3rd Watch News

Global and Asia Pacific Cell Culture Supporting Instrument Market Research Report 2020 CoronaVirus Efect on Industry and Companies, Thermo Fisher…

By Stell Cell Research

Global Coronavirus pandemic has impacted all industries across the globe, Cell Culture Supporting Instrument market being no exception. As Global economy heads towards major recession post 2009 crisis, Cognitive Market Research has published a recent study which meticulously studies impact of this crisis on Global Cell Culture Supporting Instrument market and suggests possible measures to curtail them. This press release is a snapshot of research study and further information can be gathered by accessing complete report. To Contact Research Advisor Mail us @ [emailprotected] or call us on +1-312-376-8303.

Cognitive Market Research has added a new research report to their collection titled: Cell Culture Supporting Instrument Market. In the research report various factors of the market & industry on the whole have been studies/researched and compiled together. Various in-depth factors explained in the report are: size of the industry, drivers, challenges faced by the market/restraints, opportunities, forecast analysis, regional analysis and various other factors that show the entire market functioning.

Manufacturers are facing continued downward pressure on demand, production and revenues as the COVID-19 pandemic strengthens.manufacturers should be prepared for major global supply chain disruptions. Thus, some of the key players are mainly focusing on research & development to provide inovative products to clint. The report provides an in-depth analysis regarding key players of the market along with their company profiles that contains all the information of its happening and recent developments. Various factors influencing the market development and growth as well as latest development strategies implemented by key players that can influence the growth of the market is explained. Thermo Fisher Scientific Inc. U.S., Merck KGaA Germany, GE Healthcare U.K., Lonza Group AG Switzerland, Becton Dickinson and Company U.S., Corning Inc. U.S., Eppendorf AG Germany, Hi Media Laboratories India, Sartorius AG Germany, Promocell GmbH Germany are some of the key players operating in this market.

Enquire Here For Discount (COVID-19 Impact Analysis Updated Sample): Click Here> Download Sample Report of Cell Culture Supporting Instrument Market Report 2020 (Coronavirus Impact Analysis on Cell Culture Supporting Instrument Market)

The global Cell Culture Supporting Instrument Market can be segmented into various type and application. All the type and application segments have been analyzed based on present and future trends and the market is estimated from 2020 to 2027. Moreover, study also provides quantitative and qualitative analysis of each type to understand the driving factors for the fastest growing type segment for Cell Culture Supporting Instrument market.

Global Cell Culture Supporting Instrument Market Segmentation: By Types Cell Counters, Filtration Systems, Centrifuges, CO2 Incubators, Autoclaves, Microscopes, Biosafety Cabinets, Others

Global Cell Culture Supporting Instrument Market segmentation: By Applications Biopharmaceutical/Therapeutics, Stem Cell Technology, Cancer Research, Drug Screening & Development, Tissue Engineering & Regenerative Medicine, Others

Take Note that: The Covid-19 situation and its impacts are studied by our analysts in such a way that the recovery state post covid-19 of the market is explained which shows lucrative rate for the manufacturers and producers. And also, other information related to Covid-19 like: consumer behaviour, impact on industry & market, latest strategies that can benefit the market players is explained in the report.

Free report sample of Cell Culture Supporting Instrument Market available: https://www.cognitivemarketresearch.com/medical-devicesconsumables/cell-culture-supporting-instrument-market-report#download_report

The Cell Culture Supporting Instrument research report contains executive summary, market introduction & analysis, industry analysis, key-players & their in-depth information, raw-materials and various other parameters. All the data is provided in theory as well as with help of graphical representations like: graphs, tables, charts etc as this can make it easy for a decision maker to understand the information briefly & in easier manner. The global level opportunities and position of the market along with the challenges are explained in-depth in the report. The report showcases data form the base year 2020 till the forecast year 2027 along with the revenue and compound annual growth rate. The report also provides historical data for the year 2015 to 2019.

Advantages of purchasing the Cell Culture Supporting Instrument Market report: XXX research report provides all the necessary information from introduction to conclusion by covering every aspect, scenario and latest development of the market. Hence it provides entrepreneurs, decision makers to strengthen their firms, start-up companies and other influencers of a company to improvise and implement the factors mention in the report. Some of the crucial factors that are of interest to the companies have been specifically identified & studied. For instance, market segmentation, revenue, Covid-19 impact, forecast analysis, major players, regional analysis, product types & applications, new innovation strategies & product introduction and various other factors have been regarding growth of the market have been mentioned. Hence this report can serve as an informative blueprint for a business.

Customization of report available: According to the needs of the buyer we customize the parts that are essential for your business. Connect with us to know more and to get all the information regarding the research report based on what suits you. Checkout Inquiry for Buying or Customization of Report: https://www.cognitivemarketresearch.com/medical-devicesconsumables/cell-culture-supporting-instrument-market-report#download_report.

The report also provides regional data analysis for North America, Europe, Asia Pacific, South America, and the Middle East and Africa. Furthermore, it highlights the specific region that holds higher revenue as compare to the other regions and explains reason responsible for this upper hand of particular region. The Cell Culture Supporting Instrument research report also covers various drivers of the market, opportunities & restraints. It also provides information related to the overall market by evaluating various elements to provide the SWOT & PESTEL analysis. Overall information covering all the factors, aspects, scenarios& situations of the market on a global standard have been mentioned in the research report.

About Us: Cognitive Market Research is one of the finest and most efficient Market Research and Consulting firm. The company strives to provide research studies which include syndicate research, customized research, round the clock assistance service, monthly subscription services, and consulting services to our clients. We focus on making sure that based on our reports, our clients are enabled to make most vital business decisions in easiest and yet effective way. Hence, we are committed to delivering them outcomes from market intelligence studies which are based on relevant and fact-based research across the global market. Contact Us: +1-312-376-8303 Email: [emailprotected] Web: https://www.cognitivemarketresearch.com/

Excerpt from:
Global and Asia Pacific Cell Culture Supporting Instrument Market Research Report 2020 CoronaVirus Efect on Industry and Companies, Thermo Fisher...

Growing Focus on Product Innovation Likely to Impact the Growth of the Animal Stem Cell Therapy Market 2017 2025 – Cole of Duty

By Stem Cell Clinic

A new intelligence report Animal Stem Cell Therapy Market has been recently added to Adroit Market Research collection of top-line market research reports. Global Animal Stem Cell Therapy Market report is a meticulous all-inclusive analysis of the market that offers access to direct first-hand insights on the growth trail of market in near term and long term. On the basis of factual information sourced from authentic industry experts and extensive primary industry research, the report offers insights on the historic growth pattern of Animal Stem Cell Therapy Market and current market scenario. It then provides short- and long-term market growth projections.

Projections are purely based on the detailed analysis of key market dynamics that are expected to influence Animal Stem Cell Therapy Market performance and their intensity of impacting market growth over the course of assessment period.

Request Sample Report @ https://www.persistencemarketresearch.co/samples/14941

In addition to evaluation of dynamics, the report provides in-depth examination of key industry trends that are expected to act more prominently in global Animal Stem Cell Therapy Market. The study also offers valued information about the existing and upcoming growth opportunities in Animal Stem Cell Therapy Market that the key players and new market entrants can capitalize on.

Competitive companies and manufacturers in global market

Key Participants

The key participants in the animal stem cell therapy market are Magellan Stem Cells, ANIMAL CELL THERAPIES, Abbott Animal Hospital, VETSTEM BIOPHARMA, Veterinary Hospital and Clinic Frisco, CO, etc. The companies are entering into the collaboration and partnership to keep up the pace of the innovations.

The report covers exhaustive analysis on:

Regional analysis for Market includes

Report Highlights:

Request Report Methodology @ https://www.persistencemarketresearch.co/methodology/14941

Opportunity assessment offered in this Animal Stem Cell Therapy Market report is important in terms of understanding the lucrative areas of investment, which prove to be the actionable insights for leading market players, suppliers, distributors, and other stakeholders in Animal Stem Cell Therapy Market.

In-depth global Animal Stem Cell Therapy Market taxonomy presented in this report provides detailed insights about each of the market segments and their sub-segments, which are categorized based on t par various parameters. An exhaustive regional analysis of global Animal Stem Cell Therapy Market breaks down global market landscape into key geographies.

Regional outlook and country-wise analysis of Animal Stem Cell Therapy Market allows for the evaluation of multi-faceted performance of market in all the key economies. This information intends to offer a broader scope of report to readers and identify the most relevant profitable areas in global market place.

Key Regions and Countries Covered in Global Animal Stem Cell Therapy Market Report-

Taxonomy and geographical analysis of the global Animal Stem Cell Therapy Market enables readers to spot profits in existing opportunities and capture upcoming growth opportunities even before they approach the market place. The analysis offered in report is purely intended to unroll the economic, social, regulatory and political scenarios of the market specific to each region and country, which could help potential market entrants in Animal Stem Cell Therapy Market landscape to understand the nitty-gritty of target market areas and devise their strategies accordingly.

For any queries get in touch with Industry Expert @ https://www.persistencemarketresearch.co/ask-an-expert/14941

Animal Stem Cell Therapy Market Table of Contents

See the original post here:
Growing Focus on Product Innovation Likely to Impact the Growth of the Animal Stem Cell Therapy Market 2017 2025 - Cole of Duty

Postdoctoral Fellow, Department of Chemistry job with THE UNIVERSITY OF HONG KONG | 213493 – Times Higher Education (THE)

By Stem Cell Medicine

Work type: Full-time Department: Department of Chemistry (25200) Categories: Academic-related Staff

Applications are invited for appointment as Post-doctoral Fellow (several posts) in the Department of Chemistry (Ref.: 500595), to commence as soon as possible for one year, with the possibility of renewal.

Applicants should possess a Ph.D. degree in Chemistry, Biomedical Science or a related discipline from a local university focusing on the following four research programs: (i) Synthetic Chemistry; (ii) Chemical Biology of Natural Products and Chinese Medicine; (iii) Metal Anticancer Medicine, Diagnostics and Theranostics; and (iv) Multi-Omics and Innovative Analytical Technologies for Health. Applicants from non-local universities are welcome to apply if the qualification awarding institution is among the top 100 institutions (i.e. in the latest publication of any of the following world university ranking tables: (1) Quacquarelli Symonds World University Rankings, (2) Shanghai Jiao Tong University (Academic Ranking of World Universities), or (3) Times Higher Education World University Rankings). They should have a good research publication record and research experience in at least one of the research areas including catalysis, organic synthesis, bioinorganic chemistry, medicinal chemistry, Chinese medicine, natural products, metal-based therapeutics and diagnostics, bioimaging, mass spectrometry, proteomics, metabolomics, cancer biology and pharmacology, cancer stem cells and animal models of cancers. They should also have the ability to work independently as well as in a team, and be self-motivated. The appointees will participate in the ITC projects and join the Laboratory led by Professor Chi-Ming Che which integrates chemical science and biomedical science for the development of new molecular medicines and diagnostics tools for the treatment and analysis of human diseases with a focus on cancer. They will conduct research on synthetic chemistry, chemical biology, cell biology and drug discovery and work with a multidisciplinary team of chemists and biologists. Working off-campus may be required.

A highly competitive salary commensurate with qualifications and experience will be offered, in addition to annual leave and medical benefits. At current rates, salaries tax does not exceed 15% of gross income.

Applicants should apply online and upload a cover letter, an up-to-date C.V. and 2 reference letters. Review of applications will commence as soon as possible and continue until December 31, 2020, or until the posts are filled, whichever is earlier.

See the article here:
Postdoctoral Fellow, Department of Chemistry job with THE UNIVERSITY OF HONG KONG | 213493 - Times Higher Education (THE)

HIV patient ‘first in remission’ without transplant – Japan Today

By Stem Cell Treatment

A HIV-positive man in remission may be the first patient effectively cured of the illness without needing a bone marrow transplant, researchers said Tuesday in a potential breakthrough.

HIV affects tens of millions of people globally and while the disease is no longer the automatic death sentence it once was, patients need to take medication for life.

In recent years two men -- known as the "Berlin" and "London" patients -- appear to have been cured of the disease after undergoing high-risk stem cell bone marrow transplants to treat cancer.

Now an international team of researchers believe they may have a third patient who no longer shows sign of infection after undergoing a different medicine regimen.

The patient, a 34-year-old Brazilian who has not been named, was diagnosed with HIV in 2012.

As part of the study, he was given several potent antiviral drugs, including maraviroc and dolutegravir, to see if they could help him rid the virus from his body.

He has now gone more than 57 weeks with no HIV treatment and he continues to test negative for HIV antibodies.

Ricardo Diaz, an infectious diseases expert at the University of Sao Paulo, said the patient could be considered to be free of the disease.

"The significance for me is that we had a patient that was on treatment and he is now controlling the virus without treatment," he told AFP.

"We're not able to detect the virus and he's losing the specific response to the virus -- if you don't have antibodies then you don't have antigens."

Diaz's findings were released as part of the first-ever all-virtual International AIDS Conference, held online this year due to the coronavirus pandemic.

The United Nations said Monday that 1.7 million people contracted HIV last year and there are now more than 40 million people living with it.

Diaz said his team's treatment method, which needs further research, was a more ethical avenue for gravely ill HIV sufferers than the bone-marrow transplant route.

"They come with a high mortality rate, there have been a series of patients who have either died from the procedures or it didn't work," he said.

Sharon Lewin, co-Chair of the International AIDS Society Initiative Towards an HIV Cure and director of the Doherty Institute for Infection and Immunity in Melbourne, said Diaz's findings were "very interesting".

She struck a note of caution however, due to the study's limitations.

She noted that the Brazil patients' antibody test had gotten weaker over time -- suggesting a diminishing immune response.

"This is very unusual to see in someone off antivirals," she said. "The Berlin and London Patients may be the only exceptions. This very provocative data needs more in-depth analysis."

Originally posted here:
HIV patient 'first in remission' without transplant - Japan Today

June 2020 Edition, Global Cell Culture Supporting Equipment Market Study 2020 Drivers, Restraints and Trends Included Companies Thermo Fisher…

By Stem Cell Medicine

We have recently published Following Report Edition with COVID-19 Impact Analysis included 1) Global Edition of Cell Culture Supporting Equipment Market Report 2020 2) Europe Edition of Cell Culture Supporting Equipment Market Report 2020 3) United States Edition of Cell Culture Supporting Equipment Market Report 2020

Global Coronavirus pandemic has impacted all industries across the globe, Cell Culture Supporting Equipment market being no exception. As the Global economy heads towards major recession post-2009 crisis, Cognitive Market Research has published a recent study which meticulously studies the impact of this crisis on Global Cell Culture Supporting Equipment market and suggests possible measures to curtail them. This press release is a snapshot of the research study and further information can be gathered by accessing a complete report.To Contact Research experts Mail us @ [emailprotected] or call us on +1-312-376-8303.

Download Report Preview from here: https://www.cognitivemarketresearch.com/medical-devicesconsumables/cell-culture-supporting-equipment-market-report#download_report

The research team of Cognitive Market Research has formulated and compiled a new research report on Cell Culture Supporting Equipment market. The Cell Culture Supporting Equipment research report contains the overall market information like industry analysis, market size & share, forecast analysis, market drivers, market opportunities market restraints, region analysis, growth analysis, latest trends and Covid-19 impact analysis. The data present in the research report is represented in the form of graphs, tables and charts to have a detailed understanding of the entire market. Hence through a close study on all the functions, aspects and scenarios of the market & the industry, the Cell Culture Supporting Equipment research report has been compiled.

Download Free Report Preview from here: https://www.cognitivemarketresearch.com/medical-devicesconsumables/cell-culture-supporting-equipment-market-report#download_report

Global Cell Culture Supporting Equipment Market Segmentation by Type: Cell Counters, Filtration Systems, Centrifuges, CO2 Incubators, Autoclaves, Microscopes, Biosafety Cabinets, Others

Global Cell Culture Supporting Equipment Market Segmentation by Applications: Biopharmaceutical/Therapeutics, Stem Cell Technology, Cancer Research, Drug Screening & Development, Tissue Engineering & Regenerative Medicine, Other

Major Market players of the Cell Culture Supporting Equipment market: Thermo Fisher Scientific US, Merck KGaA Germany, GE Healthcare US, Lonza Switzerland, Becton Dickinson and Company US, Corning Incorporated US, Eppendorf Germany, HiMedia Laboratories India, Sartorius AG Germany, PromoCell GmbH Germany, Pall Corporation acquired by Danaher US, Irvine Scientific US, InvivoGen US, CellGenix GmbH Germany

Each of the companies/key players consists of detailed information like: company introduction/overview (competitors, sales area, contact info, business segments and overall information), product portfolio, net sales & revenue, research & development costs, product specifications & information, latest news of the company, swot analysis and business strategy of the company is explained. And hence the entire information related to the company concerning the specific product and in-depth information of collaborations and all other essential information is mention in each of the key payer/company profiles is provided in the research report.

Any query? Enquire Here For Discount (COVID-19 Impact Analysis Updated Sample): Click Here> Download Sample Report of Cell Culture Supporting Equipment Market Report 2020 (Coronavirus Impact Analysis on Cell Culture Supporting Equipment Market)

The region analysis consists of different regions taken into consideration for the study like: North America, Europe, Asia Pacific, Latin America, Middle East and Africa. All the information regarding the major shareholder among all the regions & the reasons and other factors that aid in the market growth are explained with a very close assessment on the entire market. The analysis regarding all the companies and regions aids in providing analysis for the Cell Culture Supporting Equipment Market globally and provides information that is represented through graphs to show region analysis. The Cell Culture Supporting Equipment Market brochure:

Regions included in the Cell Culture Supporting Equipment Market research report are: North America Europe Asia Pacific Latin America The Middle East and Africa

Highlights on offerings of the research report for Cell Culture Supporting Equipment Market: Overall market assessment concerning industry offerings, region analysis and other essentials like (size of the market, market revenue etc) of the market overall. Key players along with detailed information of the companies playing a major role in the Cell Culture Supporting Equipment Market. Cell Culture Supporting Equipment Market analysis like: Market drivers, market opportunities, market restraints, Product type analysis and application analysis. Covid-19 impact on the market & industry, consumer behaviour, recovery &forecast analysis. Various strategies and impacts, in-depth analysis and major key factors for the Cell Culture Supporting Equipment market wholly are mentioned in the research report. Conclusion explaining the future market position and all the latest happenings in the market. DOWNLOAD FREE SAMPLE [emailprotected]: https://www.cognitivemarketresearch.com/medical-devicesconsumables/cell-culture-supporting-equipment-market-report#download_report

Reasons to purchase the research report: Provides in-depth research analysis of the overall Cell Culture Supporting Equipment market. which can help save time for entrepreneurs looking to start business regarding the Cell Culture Supporting Equipment Market. Various trending news, forecast analysis and key competitors of the market are easily available with all the necessary information. Entire market scope and information can be available at the fingertips for any entrepreneur or company that purchases the report which can help a start-up company or a competitor understand the Cell Culture Supporting Equipment Market in detail with all the necessary factors. Graphs, pie charts and other representations that can help the reader understand the information at a single glance. All necessary information regarding the market that can help a manufacturer understand the consumer behaviour, business segments and sell products based on the research information. Most trending Coronavirus pandemic impact on the market and industry with all the necessary recovery analysis.

Cell Culture Supporting Equipment Research Report Inspects: Product Type and Applications Covid-19 Impact analysis Key players/companies of Cell Culture Supporting Equipment Market globally The report is available as individual chapters according to your need or specific region highlighted report. To check the complete Table of Content click here: @ https://www.cognitivemarketresearch.com/medical-devicesconsumables/cell-culture-supporting-equipment-market-report#table_of_contents

About Us: Cognitive Market Research is one of the finest and most efficient Market Research and Consulting firm. The company strives to provide research studies which include syndicate research, customized research, round the clock assistance service, monthly subscription services, and consulting services to our clients.

Contact Us: +1-312-376-8303 Email: [emailprotected] Web: https://www.cognitivemarketresearch.com

- DOWNLOAD FREE SAMPLE [emailprotected]: https://www.cognitivemarketresearch.com/medical-devicesconsumables/cell-culture-supporting-equipment-market-report

Continued here:
June 2020 Edition, Global Cell Culture Supporting Equipment Market Study 2020 Drivers, Restraints and Trends Included Companies Thermo Fisher...

Stem Cell Research Breakthrough Shows Promise for Treating …

By Stell Cell Research

A research study in mice by investigators at the University of Rochester Medical Center (URMC) suggests it would be possible to repair the brain cell damage caused by multiple sclerosis (MS). The research was published in the journalCell Reports.

The research, led by Steve Goldman, professor of Neurology and Neuroscience at URMC and co-director of the Center for Translational Neuromedicine, manipulated embryonic and induced pluripotent stem cells to create glia, a type of brain cell. Glial progenitor cells, a subtype of these cells, eventually form the primary support cells of the brain, astrocytes and oligodendrocytes, which play essential roles in the health and signaling behavior of nerve cells.

MS is an autoimmune disorder where the bodys immune system attacks oligodendrocytes. Oligodendrocytes manufacture myelin, which makes the insulation that allows nerve cells to communicate with each other. As myelin decreases in MS, the signaling between nerve cells is interrupted, which causes the loss of function that leads to problems with sensation, motor function and cognitive problems.

In relapsing MS, which is an early part of the disease process, oligodendrocytes replenish the damaged myelin. But as the disease progresses, oligodendrocytes cant keep up and MS becomes worse and irreversible.

These findings demonstrate that through the transplantation of human glial cells, we can effectively achieve remyelination in the adult brain, Goldman said. These findings have significant therapeutics implications and represent a proof-of-concept for future clinical trials for multiple sclerosis and potential other neurodegenerative diseases.

Goldman and his team transplanted human glial progenitor cells into adult mouse models of progressive MS. The cells traveled to the needed location in the brain of the mice, manufactured new oligodendrocytes and replaced the damaged and missing myelin. The process of remyelination resulted in restored motor function in the laboratory animals.

The scientists speculate that this approach might be applied to other neurological diseases, such as pediatric leukodystrophies and certain kinds of strokes in adults.

Goldman is the scientific founder of a biotech company, Oscine Therapeutics, which is working to leverage the technology for therapeutics for MS and other glial diseases, such as Huntingtons disease. The companys most advanced pipeline product is currently under review by the U.S. Food and Drug Administration (FDA) with hopes of it beginning clinical trials for Huntingtons disease sometime this year.

In 2019, Sana Biotechnology invested in Oscine. The financial details were not disclosed, but the research was being run at URMC under a sponsored research deal and supports 21 full-time staff, with researchers in Rochester, Seattle and New York City.

At the time, company chief executive officer, Christina Trojel-Hansen, who also co-founded the company with Goldman, said, Cell-based therapies hold significant promise, and while progress has been made in areas such as cancer, there is a significant unmet need in diseases of the central nervous system. The support from Sana will enable us to advance important research in this field and work with an established team that has experience in bringing cell-based therapies through clinical trials and into clinical practice. I am also deeply grateful for the team at the University of Rochester for their efforts to ensure that these important scientific studies can now advance toward a clinical application.

Both the University of Rochester and Cornell University have licensed intellectual property to Oscine. The University of Rochester and Goldman hold equity in the company. Goldman acts as the companys president.

Link:
Stem Cell Research Breakthrough Shows Promise for Treating ...

MEDICAL ANIMATION MARKET COMPETITIVE STRATEGIES AND WORLDWIDE DEMAND WITH TOP PLAYERS-INFUSE MEDIA GROUP, LLC., HYBRID MEDICAL ANIMATION, GHOST…

By Gene Therapy Clinics

Global Medical Animation Market By Type (3D Animation, 2D Animation, Real Time Imaging (4D Animation), Flash Animation), Therapeutic Area (Oncology, Cardiology, Cosmeceuticals/Plastic Surgery, Dental, Others), Application (Drug Mechanism of Action (MOA) and Approval, Patient Education, Surgical Training and Planning, Cellular and Molecular Studies, Others), End-Users (Life Science Companies, Medical Device Manufacturers, Hospitals, Surgical Centers, and Clinics, Academic Institutes, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa), Market Trends and Forecast to 2027

Medical animation market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account for USD 917.82 million by 2027 growing at a CAGR of 20.4% in the above-mentioned forecast period. Increasing usage of medical animation in the marketing of the pharmaceutical products is expected to create opportunity for the market.

To Remain Ahead Of Your Competitors, Request for a FREE Sample Here (with covid 19 Impact Analysis) @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-medical-animation-market&pm

The major players covered in the medical animation market report are INFUSE MEDIA GROUP, LLC., Hybrid Medical Animation, Ghost Productions, Inc., Scientific Animations Inc., INVIVO Communications Inc., Random42 Scientific Communication, AXS Studio, Visible Body, Animated Biomedical Productions, XVIVO Scientific Animation, Blausen Medical, Trinsic Animation, Understand.com, LLC., Medmovie.com, Polygon Animation Ltd., Trinity Animation, Syntropy, STATICS & SPARKLE, Vee Create among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Medical animation is type of a small educational film which usually consist information on surgical and physiological topic. These animations are usually made with the help of the 3D computer graphics.

Increasing adoption of medical animation by life science & medical device companies is expected to enhance the market growth. Some of the other factors such as growth in the pharmaceutical & medical device industry, rising usage of smartphones & tablets, increasing aging population, rising number of surgeries and growing demand for advanced techniques is anticipated to drive the market growth in the forecast period of 2020 to 2027.

Some of the factors such as high cost of the medical animation services and lack of certified medical animators will also hamper the growth of this market.

This medical animation market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research medical animation market contact us for anAnalyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Medical Animation Market Scope and Market Size

Medical animation market is segmented of the basis of type, therapeutic area, application and end-users. The growth amongst these segments will help you analyse market growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

Medical Animation Market Country Level Analysis

Medical animationmarket is analysed and market size insights and trends are provided by country, type, therapeutic area, application and end-users as referenced above.

The countries covered in the medical animation market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Buy this Report (Can be used by entire organization across the globe + Downloadable and Printable PDF + 30 + Countries) @https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-medical-animation-market&pM

North America dominates the medical animation market in the forecast period of 2020 to 2027. This is due to increasing healthcare spending, presence of various pharmaceutical company and increasing number of surgeries in the country.

The country section of the medical animation market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

Medical animation market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipments, installed base of different kind of products for medical animation market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the medical animation market. The data is available for historic period 2010 to 2018.

Key Pointers Covered in the Medical Animation Market Industry Trends and Forecast to 2027

Competitive Landscape and Medical Animation Market Share Analysis

Medical animation market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies focus related to medical animation market.

Medical animation market has shown an exceptional penetration in developed economies in North America. Surging number of surgeries, prevalence of pharmaceutical companies and rising healthcare expenditure will uplift the growth of the market.

Medical Animation Market Scenario

According to Data Bridge Market Research the medical animation market is witnessing a significant growth in developing economies during the forecast period of 2020-2027 due to factors such as adoption of smart phones and tablets, increasing number of surgeries, growing geriatric population along with growth of medical device industry and adoption of animation by the life science and medical device companies will boost the growth of the market.

Now the question is which are the other regions that medical animation market is targeting? Data Bridge Market Research has forecasted a large growth in Asia-Pacific medical animation market in the forecast period of 2020-2027. The Data bridge market research new reports highlight the major growth factors and opportunities in the medical animation market.

New Medical Animation Market Development in 2019

Scope of the Medical Animation Market

Medical animation market is segmented on the basis of countries into U.S., Canada, Mexico in North America, Brazil, Argentina, Rest of South America as a part of South America, Germany, France, U.K., Italy, Spain, Netherlands, Belgium, Russia, Turkey, Switzerland, Rest of Europe in Europe, China, Japan, India, Australia, Singapore, Thailand, Malaysia, South Korea, Indonesia, Philippines, Rest of Asia-Pacific (APAC) as a part of Asia-Pacific (APAC), U.A.E, Egypt, Saudi Arabia, South Africa, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

Key Market Competitors Covered in the report

Register Here @https://www.databridgemarketresearch.com/digital-conference/cell-and-gene-therapy?pm

About Data Bridge Market Research:

Data Bridge Market Researchset forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email:[emailprotected]

Read more:
MEDICAL ANIMATION MARKET COMPETITIVE STRATEGIES AND WORLDWIDE DEMAND WITH TOP PLAYERS-INFUSE MEDIA GROUP, LLC., HYBRID MEDICAL ANIMATION, GHOST...

Death in Cellectis off-the-shelf CAR-T trial triggers FDA hold – FierceBiotech

By Stem Cell Treatment

The FDA has put a phase 1 trial of Cellectis off-the-shelf CAR-T therapy UCARTCS1A on clinical hold after learning of a death in the study. Cellectis said the multiple myeloma patient suffered a cardiac arrest after receiving the highest dose of the anti-CS1 allogeneic CAR-T.

Before joining the Cellectis trial, the patient underwent multiple prior lines of treatment, including with autologous CAR-T cells, without success. In the Cellectis trial, the patient was the first person to receive the higher, 3 million cells per kilogram dose of UCARTCS1A. The patient experienced cytokine release syndrome of undisclosed severity and died of a cardiac arrest 25 days after treatment.

The FDA has placed the trial on clinical hold while Cellectis evaluates the case. According to Cellectis, plans were already afoot to expand the lower, 1 million cells per kilogram dose cohort before the patient death. Preliminary data suggest 1 million cells per kilogram may be the phase 2 dose.

Clinical Inks intimate knowledge of and experience with GI trials enables a better deployment experience and improved trial conduct. Learn how our GI-specific data capture solutions can support virtual and hybrid trials during COVID-19.

There are signs the lower dose also has some safety issues. Analysts at Jefferies think investigators gave one or more of the three low-dose patients rituximab to activate the CAR-T safety switch. Work is underway to update the phase 1 protocol to mitigate the potential risks posed by UCARTCS1A.

The modifications may include increased monitoring of parameters related to cytokines. The Jefferies analysts think Cellectis should exclude patients previously treated with anti-BCMA CAR-Ts, such as Johnson & Johnsons JNJ-4528, due to risks related to back-to-back rounds of lymphodepletion, but note that management at the biotech think it is important to enroll that pre-treated population.

In a follow-up note, the analysts identified the use of cyclophosphamide, a chemotherapy drug, in the lymphodepletion regimen as a potential cause of the cardiac arrest. The argument is based on a 2017 paper that describes the case of a patient who died of acute heart failure after receiving a high dose of cyclophosphamide as part of an autologous stem cell transplantation treatment.

Many patients receive cyclophosphamide without suffering cardiac complications, but the analysts see reasons to think the subject enrolled in the Cellectis trial may have been at higher risk. Notably, prior exposure may increase risk, according to the analysts, suggesting the patients previous round of lymphodepletion may have been a factor.

Even if cyclophosphamide is at the heart of the problem, the analysts still think the UCARTCS1A dose is a contributing factor. With patients in the low-dose cohort also experiencing adverse events, the analysts see dosing at below 1 million cells per kilogram as one possible outcome of the situation.

Shares in Cellectis fell 13% in after-hours trading following news of the clinical hold. The value of Allogene Therapeutics, which licensed CAR-T assets that originated at Cellectis, held steady, likely reflecting a belief that the safety issue is limited to UCARTCS1A.

The Jefferies analysts see little or no read-through to other allogeneic programs, noting that the UCARTCS1A trial started at a higher dose than Cellectis two other clinical programs and that Allogene is testing several lymphodepletion regimens. The FDA placed a clinical trial of another Cellectis CAR-T, UCART123, on hold in 2017 after a patient died, but cleared it to resume months later.

Follow this link:
Death in Cellectis off-the-shelf CAR-T trial triggers FDA hold - FierceBiotech

Ryan Anthony: A local trumpet prodigy who went on to play big stages and raise funds for cancer research – The San Diego Union-Tribune

By Stem Cell Doctors

To hear his wife tell it, world-renowned trumpeter Ryan Anthony was still planning his next musical project even as his body succumbed to a rare form of cancer.

I know that he always wanted more, Niki Anthony says. Up until the day before he passed, he was talking about the next recording he wanted to do. Even though he knew it was unlikely hed ever get out of the hospital, he always lived with hope.

In talking with his friends and family, Ryan Anthony, who passed away at a Dallas hospital on June 23 at the age of 51, was unceasingly hopeful throughout his life. From his days growing up a trumpet prodigy in San Diego to his final performances with the Dallas Symphony Orchestra, he lived a life of filled with a sense of spirited optimism. A spirit he shared throughout a multifaceted career as a musician, educator and philanthropist.

From the time Ryan was born on May 17, 1969, people began to notice his innate attraction to music. Ryans older brother, RB Anthony, says that music was always playing in their familys East County home.

Music was with us from the beginning. We were both performing from an early age, says RB, who says Ryan began playing trumpet in elementary school. Our father had us with his music groups and out on marching fields from when we were 2 years old, so music was a natural thing to develop for us. We had some natural talent, but Ryan just knew what to do with it. Im a musician and I still enjoy it, but he knew how to practice it.

Ryans father, Roy, was the musical director at Mount Miguel High School in Spring Valley, where Ryan also attended. At home, Ryan and RB would dutifully listen to recordings of Doc Severinsen, as well as big band music and movie scores. At 16, Ryan won the Seventeen Magazine & General Motors Concerto Competition.

Even back then, he was probably one of the best musicians in California and had the awards to prove it, says local drummer Jeffrey Lee Hawthorne, who was good friends with Ryan in high school. His musicianship at 16, 17 years old was already so far superior to anyone else. We knew he was going places.

After graduating high school, Ryan received a four-year scholarship to the Cleveland Institute of Music, where he earned two degrees. He went on to become a trumpet professor at the Oberlin Conservatory in Oberlin, Ohio.

Trumpeter Ryan Anthony

(Courtesy photo by Jeremy Lock)

One of Niki Anthonys earliest memories of Ryan was hearing him play trumpet at Lindenwood Christian Church in Memphis in 1992, where she performed with the church choir.

You could just hear a different sound in his tone and phrasing, remembers Niki. It was like you could hear the story behind the music even though there werent any words. As a singer, I always related to music a lot through words and text, so it was really something for me to pay attention to an instrumentalist and hear the story there.

While Ryan and Niki didnt begin dating until a few years later he was living in Salt lake City and she in Memphis she says she knew from the early days of their relationship that Ryans chosen profession would likely mean a life on the road and having to move around.

Still, even after they were married in 1997 and Ryan began touring with prestigious ensembles such as the Canadian Brass in 2000, Niki says she always wanted to remain supportive when it came to Ryans musical dreams.

For me, it was always important to let him have that freedom so he could be who he was, Niki says. His music was important to a lot of people, and that was important to me, too.

A few years after his appointment to the Canadian Brass, the couple welcomed their first child, daughter Elizabeth (Lili). Four years later, they had a son, Rowan. At the same time, Ryan performed as a soloist with over 30 ensembles and played at dozens of music festivals all over the world.

Trumpeter Ryan Anthony

(Courtesy photo)

Life began to settle a bit for Ryan Anthony in 2004 when he accepted an invitation to join the Dallas Symphony Orchestra (DSO) as a guest principal trumpet. Within four years, he was promoted to principal trumpet in the orchestra.

When he first started playing with us, we quickly became aware of his extreme ability, both in his musicianship and his playing, says Kevin Finamore, a fellow trumpeter who met Ryan in 2005 when the two were performing together in the DSO.

The bigger the stage, the better he was, Finamore continues. Hes just a natural-born performer like no other.

Ryan Anthonys November 2012 diagnosis of multiple myeloma, a rare form of cancer affecting the white blood cells, was terminal. He visited multiple doctors, but they all agreed that Ryan had about three years to live. He made it almost to eight years.

I remember the day he was diagnosed. He called me, and he told me he had decided that it wasnt going to break his spirit, Finamore says. Even to the end, he had a smile on his face. He would play through the pain. He would walk onstage, totally miserable, and some of the best playing he did was when he felt horrible. It was amazing.

In that time, between stem cell transplants and multiple rounds of chemotherapy, he continued to perform with the Dallas Symphony and, in 2013, toured as the guest principal trumpet with the San Diego Symphonys tour of China. In 2016, he became a professor of trumpet at Southern Methodist Universitys Meadows School of the Arts in Dallas.

There was something endearing and extremely real about Ryan, says Samuel Holland, the dean of the Meadows School. He goes on to point out that many of Ryans students would go on to land prestigious jobs in music. They could see through his own life that there was more than one way, because he had this one career as a soloist and another career as a chamber musician, and another as an orchestral musician and, ultimately, a philanthropic leader.

The latter came in 2014 in the form of the Ryan Anthony Foundation, a nonprofit organization dedicated to raising funds for blood cancer research. The organization would hold brass-based concerts called, appropriately enough, CancerBlows. Niki Anthony remembers the genesis of the foundation came when Ryan was recovering from his first stem cell transplant.

He began talking about how Doc Severinsen, Arturo Sandoval, and all these trumpet players hed played with, were calling him, Niki says. He told them that when he was healthy again, he just wanted to stand onstage with them and play again. We started joking about how a great name for this would be cancer blows and how that was funny, but then we thought why not do a concert? That would be a great celebration and a way to raise money.

The inaugural CancerBlows concerts in March 2015 featured performances from Sandoval and Severinsen, as well as members of the Canadian Brass and Dallas Symphony Orchestra. It raised over $1 million for various cancer charities.

For those who knew him, Ryans altruistic and hopeful outlook, even in the face of his own mortality, was what he was all about.

As CancerBlows became more of a thing and Ryan received more feedback from patients and their families saying that it helped them, that really fueled him, Niki says. That if he felt bad on a particular day, or didnt want to practice or play a concert, he would say, These people need me, too. For whatever reason, I have been given this, and I have a stage to provide a beacon of hope and comfort for them, and I should use it. They motivated him, and he motivated them in return.

Due to COVID-19 restrictions, Ryan Anthonys family plans to hold a public celebration of life at a later date. The family requests donations to CancerBlows and The Ryan Anthony Foundation.

Combs is a freelance writer.

Trumpeter Ryan Anthony

(Courtesy photo by Steve Roberts)

See the article here:
Ryan Anthony: A local trumpet prodigy who went on to play big stages and raise funds for cancer research - The San Diego Union-Tribune

→←